管理精神分裂症与情绪,性,代谢和物质使用并发症:来自专家共识的药理考虑
Eduard Vieta1, Ángel L Montejo2, Toby Pillinger3
1Institute of Neuroscience, University of Barcelona, Hospital Clinic, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.
Annals of general psychiatry
|December 30, 2025
概括
管理精神分裂症需要解决伴随性疾病,如情感症状和物质使用障碍. 专家建议侧重于个性化,以患者为中心的药理学策略,以获得更好的结果.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 精神分裂症是一种复杂的疾病,常常由诸如情感症状,性功能障碍,代谢问题和物质使用障碍等并发症恶化.
- 这些并发症降低治疗坚持,功能结果,并增加死亡率.
- 当前的常规护理往往不充分认识到和不充分解决这些普遍的问题.
研究的目的:
- 发展专家对精神分裂症药理学策略的共识,包括并发症管理.
- 提供适合现实世界的临床挑战和个体患者需求的指导.
主要方法:
- 一个由10名欧洲精神病学家组成的多学科小组召开了面对面的会议.
- 专家介绍了关键的并发症,随后进行了讨论.
- 一个经过修改的两轮德尔菲程序验证了共识陈述,合成成可执行的建议.
主要成果:
- 制定了四个共同疾病领域的共识建议,结合证据和临床专业知识.
- 强调个性化,以患者为中心的策略,平衡疗效,耐受性和功能.
- 确定了部分多巴胺激动剂和代谢有利的药物是有用的;解决了抗精神病药物选择,副作用管理和双重诊断护理.
- 突出基于测量的监测和综合服务,以改善结果.
结论:
- 有效的精神分裂症管理需要转向以共患病为基础的,以康复为导向的药物治疗.
- 这些建议为临床实践中的个性化治疗规划提供了实际策略.
关键词:
情感症状 情感症状 情感症状抗精神病药物 抗精神病药物伴随性疾病 伴随性疾病个性化的治疗方法代谢障碍 代谢障碍 代谢障碍药理学管理 药理学管理在现实世界中练习实践.精神分裂症是一种精神分裂症.性功能障碍性功能障碍性功能障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性障碍性药物使用障碍 药物使用障碍.相关概念视频
Drug Therapy
226
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
226
Psychosis: Goals of Pharmacotherapy
434
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
434
Psychosis and Antipsychotic Drugs: Overview
770
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
770
Antidepressant Drugs: MAOIs and Other Agents
761
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
761
Mania and Antimanic Drugs: Overview
522
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
522
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
1.8K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.8K


